Skip to main content
Top
Published in: Journal of Gastroenterology 11/2009

01-11-2009 | Original Article—Liver, Pancreas, and Biliary Tract

A prospective randomized controlled multicenter trial of duodenoscopes with 5° and 15° backward-oblique angle using wire-guided cannulation: effects on selective cannulation of the common bile duct in endoscopic retrograde cholangiopancreatography

Authors: Hiroshi Kawakami, Hiroyuki Maguchi, Tsuyoshi Hayashi, Nobuyuki Yanagawa, Atsushi Chiba, Hiroyuki Hisai, Hisato Amizuka

Published in: Journal of Gastroenterology | Issue 11/2009

Login to get access

Abstract

Background

In duodenoscopy, during endoscopic retrograde cholangiopancreatography (ERCP), a backward-oblique angle duodenoscope (BOAD) is generally used. In Japan, 15° BOAD are mainly used, but in Western countries, 5° BOAD are mostly used. In bile duct cannulation associated with ERCP, a catheter for contrast imaging is used in Japan, but wire-guided cannulation (WGC) using a papillotome is standard in Western countries. We conducted a randomized controlled multicenter trial to evaluate the contributions of different duodenoscopes using WGC to selective common bile duct cannulation.

Methods

Subjects comprised 179 consecutive patients who underwent ERCP. Patients were randomized into the 15° BOAD group (15° group, n = 90) or the 5° BOAD group (5° group, n = 89).

Results

The duodenal papilla could not be accessed endoscopically in two cases from each group. Success rates for bile duct cannulation by WGC without bow-up for the 15° and 5° groups were 85.6 and 56.2%, respectively (P < 0.01). Success rates for bile duct cannulation by WGC with bow-up for the 15° and 5° groups were 88.9 and 78.7%, respectively. Total rates of bile duct cannulation for the 15° and 5° groups were 94.4 and 92.1%, respectively. As for accidents, incidences of acute pancreatitis for the 15° and 5° groups were 5.6 and 9.0%, respectively, with no significant difference seen.

Conclusions

With 15° BOAD, bile duct cannulation was favorable without papillotome bow-up. With 5° BOAD, the success rate of WGC may be improved by adjusting the angle based on papillotome bow-up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lella F, Bagnolo F, Colombo E, Bonassi U. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc. 2004;59:830–4.CrossRefPubMed Lella F, Bagnolo F, Colombo E, Bonassi U. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc. 2004;59:830–4.CrossRefPubMed
2.
go back to reference Artifon EL, Sakai P, Cunha JE, Halwan B, Ishioka S, Kumar A. Wire-guided cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol. 2007;102:2147–53.CrossRefPubMed Artifon EL, Sakai P, Cunha JE, Halwan B, Ishioka S, Kumar A. Wire-guided cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol. 2007;102:2147–53.CrossRefPubMed
3.
go back to reference Bailey AA, Bourke MJ, Williams SJ, Walsh PR, Murray MA, Lee EY, et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008;40:296–301.CrossRefPubMed Bailey AA, Bourke MJ, Williams SJ, Walsh PR, Murray MA, Lee EY, et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008;40:296–301.CrossRefPubMed
4.
go back to reference Katsinelos P, Paroutoglou G, Kountouras JA, Chatzimavroudis G, Zavos C, Pilpilidis I, et al. A comparative study of standard ERCP catheter and hydrophilic guidewire in the selective cannulation of the common bile duct. Endoscopy. 2008;40:302–7.CrossRefPubMed Katsinelos P, Paroutoglou G, Kountouras JA, Chatzimavroudis G, Zavos C, Pilpilidis I, et al. A comparative study of standard ERCP catheter and hydrophilic guidewire in the selective cannulation of the common bile duct. Endoscopy. 2008;40:302–7.CrossRefPubMed
5.
go back to reference Lee TH, Park DH, Park JY, Kim EO, Lee YS, Park JH, et al. Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial. Gastrointest Endosc. 2009;69:444–9.CrossRefPubMed Lee TH, Park DH, Park JY, Kim EO, Lee YS, Park JH, et al. Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial. Gastrointest Endosc. 2009;69:444–9.CrossRefPubMed
6.
go back to reference Mayedo A, Borkar D. Techniques of selective cannulation and sphincterotomy. Endoscopy. 2003;35:S19–23.CrossRef Mayedo A, Borkar D. Techniques of selective cannulation and sphincterotomy. Endoscopy. 2003;35:S19–23.CrossRef
7.
go back to reference Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–93.CrossRefPubMed Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–93.CrossRefPubMed
Metadata
Title
A prospective randomized controlled multicenter trial of duodenoscopes with 5° and 15° backward-oblique angle using wire-guided cannulation: effects on selective cannulation of the common bile duct in endoscopic retrograde cholangiopancreatography
Authors
Hiroshi Kawakami
Hiroyuki Maguchi
Tsuyoshi Hayashi
Nobuyuki Yanagawa
Atsushi Chiba
Hiroyuki Hisai
Hisato Amizuka
Publication date
01-11-2009
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 11/2009
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0107-x

Other articles of this Issue 11/2009

Journal of Gastroenterology 11/2009 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Decreased production of immunoglobulin M and A in autoimmune pancreatitis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.